[1] Tousoulis D,Kampoli AM,Tentolouris C,et al.The role of nitric oxide on endothelial function.Curr Vasc Pharmacol,2012,10(1):4-18.
[2] Gkaliagkousi E,Ferro A.Nitric oxide signalling in the regulation of cardiovascular and platelet function.Front Biosci,2011,16:1873-1897.
[3] Moncada S,Higgs A.The L arginine nitric oxide pathway.N Engl J Med,1993,329(27):2002-2012.
[4] Stamler JS,Loh E,Roddy MA,et al.Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans.Circulation,1994,89(5):2035-2040.
[5] Fleming I.Molecular mechanisms underlying the activation of eNOS.Pflugers Arch,2010,459(6):793-806.
[6] Mount PF,Kemp BE,Power DA.Regulation of endothelial and myocardial NO synthesis by multi site eNOS phosphorylation.J Mol Cell Cardiol,2007,42(2):271-279.
[7] O′Kane P,Xie L,Liu Z,et al.Aspirin acetylates nitric oxide synthase type 3 in platelets thereby increasing its activity.Cardiovasc Res,2009,83(1):123-130.
[8] Kone BC,Kuncewicz T,Zhang W,et al.Protein interactions with nitric oxide synthases:controlling the right time,the right place,and the right amount of nitric oxide.Am J Physiol Renal Physiol,2003,285(2):F178-190.
[9] Frstermann U,Sessa WC.Nitric oxide synthases:regulation and function.Eur Heart J,2012,33(7):829-837.
[10] Maron BA,Michel T.Subcellular localization of oxidants and redox modulation of endothelial nitric oxide synthase.Circ J,2012,76(11):2497-2512.
[11] Bredt DS,Snyder S.Isolation of nitric oxide synthatase,a calmodulin requiring enzyme.Proc Natl Acad Sci USA,1990,87(2):682-685.
[12] Panda SP,Gao YT,Roman LJ,et al.The role of a conserved serine residue within hydrogen bonding distance of FAD in redox properties and the modulation of catalysis by Ca2+/calmodulin of constitutive nitric oxide synthases.J Biol Chem,2006,281(45):34246-34257.
[13] Loiola RA,Reis FC,Kawamoto EM,et al.Role of vascular Kinin B1 and B2 receptors in endothelial nitric oxide metabolism.Peptides,2011,32(8):1700-1705.
[14] Haynes MP,Sinha D,Russell KS,et al.Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3 kinase Akt pathway in human endothelial cells.Circ Res,2000,87(8):677-682.
[15] Yoshida S,Aihara KI,Ikeda Y,et al.Androgen receptor promotes gender independent angiogenesis in response to ischemia and is required for activation of VEGF receptor signaling.Circulation,2013,128(1):60-71.
[16] Bretón Romero R,González de Ordua C,Romero N,et al.Critical role of hydrogen peroxide signaling in the sequential activation of p38 MAPK and eNOS in laminar shear stress.Free Radic Biol Med,2012,52(6):1093-1100.
[17] Mount PF,Kemp BE,Power DA.Regulation of endothelial and myocardial NO synthesis by multi site eNOS phosphorylation.J Mol Cell Cardiol,2007,42(2):271-279.
[18] Ives SJ,Andtbacka RH,Kwon SH,et al.Heat and α1-adrenergic responsiveness in human skeletal muscle feed arteries:the role of nitric oxide.J Appl Physiol,2012,113(11):1690-1698.
[19] Peiró C,ValleJo S,Gembardt F,et al.Complete blockade of the vasorelaxant effects of angiotensin (1-7) and bradykinin in murine microvessels by antagonists of the receptor Mas.J Physiol,2013,591(Pt 9):2275-2285.
[20] Tabit CE,Shenouda SM,Holbrook M,et al.Protein kinase C β contributes to impaired endothelial insulin signaling in humans with diabetes mellitus.Circulation,2013,127(1):86-95.
[21] Balakumar P,Kathuria S,TaneJa G,et al.Is targeting eNOS a key mechanistic insight of cardiovascular defensive potentials of statins?J Mol Cell Cardiol,2012,52(1):83-92.
[22] Fleming I,Fisslthaler B,Dimmeler S,et al.Phosphorylation of Thr(495) regulates Ca(2+)/calmodulin dependent endothelial nitric oxide synthase activity.Circ Res,2001,88(11):E68-75.
[23] Chiasson VL,Quinn MA,Young KJ,et al.Protein kinase CbetaII mediated phosphorylation of endothelial nitric oxide synthase threonine 495 mediates the endothelial dysfunction induced by FK506(tacrolimus).J Pharmacol Exp Ther,2011,337(3):718-723.
[24] Lowry JL,Brovkovych V,Zhang Y,et al.Endothelial nitric oxide synthase activation generates an inducible nitric oxide synthase like output of nitric oxide in inflamed endothelium.J Biol Chem,2013,288(6):4174-4193.
[25] Kou R,Greif D,Michel T.Dephosphorylation of endothelial nitric oxide synthase by vascular endothelial growth factor.Implications for the vascular responses to cyclosporin A.J Biol Chem,2002,277(33):29669-29673.
[26] Gaete PS,Lillo MA,Ardiles NM,et al.Ca2+ activated K+ channels of small and intermediate conductance control eNOS activation through NAD(P)H oxidase.Free Radic Biol Med,2012,52(5):860-870.
[27] Chen Z,Peng IC,Sun W,et al.AMP activated protein kinase functionally phosphorylates endothelial nitric oxide synthase Ser633.Circ Res,2009,104(4):496-505.
[28] Ritchie SA,Kohlhaas CF,Boyd AR,et al.Insulin stimulated phosphorylation of endothelial nitric oxide synthase at serine 615 contributes to nitric oxide synthesis.Biochem J,2010,426(1):85-90.
[29] Kou R,Greif D,Michel T.Dephosphorylation of endothelial nitric oxide synthase by vascular endothelial growth factor.Implications for the vascular responses to cyclosporin A.J Biol Chem,2002,277(33):29669-29673.
[30] Cho DH,Choi YJ,Jo SA,et al.Nitric oxide production and regulation of endothelial nitric oxide synthase phosphorylation by prolonged treatment with troglitazone:evidence for involvement of peroxisome proliferator activated receptor (PPAR) gamma dependent and PPARgamma independent signaling pathways.J Biol Chem,2004,279(4):2499-2506.
[31] Gallis B,Corthals GL,Goodlett DR,et al.Identification of flow dependent endothelial nitric oxide synthase phosphorylation sites by mass spectrometry and regulation of phosphorylation and nitric oxide production by the phosphatidylinositol 3 kinase inhibitor LY294002.J Biol Chem,1999,274(42):30101-30108.
[32] Drew BG,Fidge NH,Gallon Beaumier G,et al.High density lipoprotein and apolipoprotein AI increase endothelial NO synthase activity by protein association and multisite phosphorylation.Proc Natl Acad Sci USA,2004,101(18):6999-7004.
[33] Boo YC,Hwang J,Sykes M,et al.Shear stress stimulates phosphorylation of eNOS at Ser(635) by a protein kinase A dependent mechanism.Am J Physiol Heart Circ Physiol,2002,283(5):H1819-1828.
[34] O′Kane PD,Reebye V,Ji Y,et al.Aspirin and clopidogrel treatment impair nitric oxide biosynthesis by platelets.J Mol Cell Cardiol,2008,45(2):223-229.
[35] O′Kane PD,Queen LR,Ji Y,et al.Aspirin modifies nitric oxide synthase activity in platelets:effects of acute versus chronic aspirin treatment.Cardiovasc Res,2003,59(1):152-159.
[36] Karmohapatra SK,Chakraborty K,Kahn NN,et al.The role of nitric oxide in aspirin induced thrombolysis in vitro and the purification of aspirin activated nitric oxide synthase from human blood platelets.Am J Hematol,2007,82(11):986-995.
[37] Chakraborty K,Khan GA,BanerJee P,et al.Inhibition of human blood platelet aggregation and the stimulation of nitric oxide synthesis by aspirin.Platelets,2003,14(7-8):421-427.
[38] Stangl V,Lorenz M,Meiners S,et al.Long term up regulation of eNOS and improvement of endothelial function by inhibition of the ubiquitin proteasome pathway.FASEB J,2004,18(2):272-279.
[39] Harvey NC,Lillycrop KA,Garratt E,et al.Evaluation of methylation status of the eNOS promoter at birth in relation to childhood bone mineral content.Calcif Tissue Int,2012,90(2):120-127.
[40] Zhang F,Snead CM,Catravas JD.Hsp90 regulates O linked β N acetylglucosamine transferase:a novel mechanism of modulation of protein O linked β N acetylglucosamine modification in endothelial cells.Am J Physiol Cell Physiol,2012,302(12):C1786-96.
[41] Du Y,Navab M,Shen M,et al.Ambient ultrafine particles reduce endothelial nitric oxide production via S glutathionylation of eNOS.Biochem Biophys Res Commun,2013,436(3):462-466.
[42] Pollock JS,Klinghofer V,Frstermann U,et al.Endothelial nitric oxide synthase is myristylated.FEBS Lett,1992,309(3):402-404.
[43] Sakoda T,Hirata K,Kuroda R,et al.Myristoylation of endothelial cell nitric oxide synthase is important for extracellular release of nitric oxide.Mol Cell Biochem,1995,152(2):143-148.
[44] Sessa WC,García Cardea G,Liu J,et al.The Golgi association of endothelial nitric oxide synthase is necessary for the efficient synthesis of nitric oxide.J Biol Chem,1995,270(30):17641-17644.
[45] Persechini A,Tran QK,Black DJ,et al.Calmodulin induced structural changes in endothelial nitric oxide synthase.FEBS Lett,2013,587(3):297-301.
[46] Piazza M,Futrega K,Spratt DE,et al.Structure and dynamics of calmodulin (CaM) bound to nitric oxide synthase peptides:effects of a phosphomimetic CaM mutation.Biochemistry,2012,51(17):3651-3661.
[47] Park JH,Jin YM,Hwang S,et al.Uric acid attenuates nitric oxide production by decreasing the interaction between endothelial nitric oxide synthase and calmodulin in human umbilical vein endothelial cells:A mechanism for uric acid induced cardiovascular disease development.Nitric Oxide,2013,32:36-42.
[48] Sasahara T,Yayama K,Matsuzaki T,et al.Na+/H+ exchanger inhibitor induces vasorelaxation through nitric oxide production in endothelial cells via intracellular acidification associated Ca2+ mobilization.Vascul Pharmacol,2013,58(4):319-325.
[49] Chen PF,Wu KK.Structural elements contribute to the calcium/calmodulin dependence on enzyme activation in human endothelial nitric oxide synthase.J Biol Chem,2003,278(52):52392-52400.
[50] Chambliss KL,Shaul PW.Estrogen modulation of endothelial nitric oxide synthase.Endocr Rev,2002,23(5):665-686.
[51] Mineo C,Shaul PW.Regulation of eNOS in caveolae.Adv Exp Med Biol,2012,729:51-62.
[52] Bucci M,Gratton JP,Rudic RD,et al.In vivo delivery of the caveolin 1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation.Nat Med,2000,6(12):1362-1367.
[53] Harvey RD,Calaghan SC.Caveolae create local signalling domains through their distinct protein content,lipid profile and morphology.J Mol Cell Cardiol,2012,52(2):366-375.
[54] Drab M,Verkade P,Elger M,et al.Loss of caveolae,vascular dysfunction,and pulmonary defects in caveolin 1 gene disrupted mice.Science,2001,293(5539):2449-2452.
[55] Razani B,Engelman JA,Wang XB,et al.Caveolin 1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities.J Biol Chem,2001,276(41) :38121-38138.
[56] Ghosh S,Gachhui R,Crooks C,et al.Interaction between caveolin 1 and the reductase domain of endothelial nitric oxide synthase.Consequences for catalysis,J Biol Chem,1998,273(35):22267-22271.
[57] Seto SW,Krishna SM,Yu H,et al.Impaired acetylcholine induced endothelium dependent aortic relaxation by caveolin 1 in angiotensin Ⅱ infused apolipoprotein E (ApoE-/-) knockout mice.PLoS One,2013,8(3):e58481.
[58] Yue L,Bian JT,GrizelJ I,et al.Apolipoprotein E enhances endothelial NO production by modulating caveolin 1 interaction with endothelial NO synthase.Hypertension,2012,60(4):1040-1046.
[59] Neckers L,Workman P.Hsp90 molecular chaperone inhibitors:are we there yet?Clin Cancer Res,2012,18(1):64-76.
[60] DesJardins F,Delisle C,Gratton JP.Modulation of the cochaperone AHA1 regulates heat shock protein 90 and endothelial NO synthase activation by vascular endothelial growth factor.Arterioscler Thromb Vasc Biol,2012,32(10):2484-2492.
[61] Fismen L,HJelde A,Svardal AM,et al.Differential effects on nitric oxide synthase,heat shock proteins and glutathione in human endothelial cells exposed to heat stress and simulated diving.Eur J Appl Physiol,2012,112(7):2717-2725.
[62] García Cardea G,Fan R,Shah V,et al.Dynamic activation of endothelial nitric oxide synthase by Hsp90.Nature,1998,392(6678):821-824.
[63] Takahashi S,Mendelsohn ME.Synergistic activation of endothelial nitric oxide synthase (eNOS) by HSP90 and Akt:calcium independent eNOS activation involves formation of an HSP90-Akt CaM bound eNOS complex.J Biol Chem,2003,278(33):30821-30827.
[64] Sato S,FuJita N,Tsuruo T.Modulation of Akt kinase activity by binding to Hsp90.Proc Natl Acad Sci USA,2000,97(20):10832-10837.
[65] Xu H,Shi Y,Wang J,et al.A heat shock protein 90 binding domain in endothelial nitric oxide synthase influences enzyme function.J Biol Chem,2007,282(52):37567-37574.
[66] Marrero MB,Venema VJ,Ju H,et al.Endothelial nitric oxide synthase interactions with G protein coupled receptors.Biochem J,1999,343(Pt 2):335-340.
[67] Erds EG,Tan F,Skidgel RA.Angiotensin I converting enzyme inhibitors are allosteric enhancers of kinin B1 and B2 receptor function.Hypertension,2010,55(2):214-220.
[68] Pouliot M,Talbot S,Sénécal J,et al.Ocular application of the kinin B1 receptor antagonist LF22-0542 inhibits retinal inflammation and oxidative stress in streptozotocin diabetic rats.PLoS One,2012,7(3):e33864.
[69] Vaniotis G,Glazkova I,Merlen C,et al.Regulation of cardiac nitric oxide signaling by nuclear β adrenergic and endothelin receptors.J Mol Cell Cardiol,2013,62C:58-68.
[70] Kuhr F,Lowry J,Zhang Y,et al.Differential regulation of inducible and endothelial nitric oxide synthase by kinin B1 and B2 receptors.Neuropeptides,2010,44(2):145-154.
[71] Golser R,Gorren AC,Leber A,et al.Interaction of endothelial and neuronal nitric oxide synthases with the bradykinin B2 receptor.Binding of an inhibitory peptide to the oxygenase domain blocks uncoupled NADPH oxidation.J Biol Chem,2000,275(8):5291-5296.
[72] Yang C,Talukder MA,VaradharaJ S,et al.Early ischaemic preconditioning requires Akt and PKA mediated activation of eNOS via serine1176 phosphorylation.Cardiovasc Res,2013,97(1):33-43.
[73] Peng B,Guo QL,He ZJ,et al.Remote ischemic postconditioning protects the brain from global cerebral ischemia/reperfusion inJury by up regulating endothelial nitric oxide synthase through the PI3K/Akt pathway.Brain Res,2012,1445:92-102.
[74] Bell RM,Yellon DM.Bradykinin limits infarction when administered as an adJunct to reperfusion in mouse heart:the role of PI3K,Akt and eNOS.J Mol Cell Cardiol,2003,35(2):185-193.
[75] Haeussler DJ,Pimentel DR,Hou X,et al.Endomembrane H Ras controls vascular endothelial growth factor induced nitric oxide synthase mediated endothelial cell migration.J Biol Chem,2013,288(21):15380-15389.
[76] Bevan HS,Slater SC,Clarke H,et al.Acute laminar shear stress reversibly increases human glomerular endothelial cell permeability via activation of endothelial nitric oxide synthase.Am J Physiol Renal Physiol,2011,301(4):F733-742.
[77] Shen Y,Croft KD,Hodgson JM,et al.Quercetin and its metabolites improve vessel function by inducing eNOS activity via phosphorylation of AMPK.Biochem Pharmacol,2012,84(8):1036-1044.
[78] Han Y,Zhang W,Tang Y,et al.l Tetrahydropalmatine,an active component of Corydalis yanhusuo W.T.Wang,protects against myocardial ischaemia reperfusion inJury in rats.PLoS One,2012,7(6):e38627.
[79] Han Y,Li X,Zhou S,et al.17 estradiol antagonizes the down regulation of ERα/NOS 3 signaling in vascular endothelial dysfunction of female diabetic rats.PLoS One,2012,7(11):e50402.
[80] Liu Z,Han Y,Li L,et al.Hydrogen sulfide donor,GYY4137,exhibits anti atherosclerotic activity in high fat fed apolipoprotein E-/- mice.Br J Pharmacol,2013,169(8):1795-1809.
[81] Altaany Z,Yang G,Wang R.Crosstalk between hydrogen sulfide and nitric oxide in endothelial cells.J Cell Mol Med,2013,17(7):879-888.
[82] Su Y,Kondrikov D,Block ER.Cytoskeletal regulation of nitric oxide synthase.Cell Biochem Biophys,2005,43(3):439-449.
[83] Knudsen HL,Frangos JA.Role of cytoskeleton in shear stress induced endothelial nitric oxide production.Am J Physiol,1997,273(1 Pt 2):H347-355.
[84] Searles CD,Ide L,Davis ME,et al.Actin cytoskeleton organization and posttranscriptional regulation of endothelial nitric oxide synthase during cell growth.Circ Res,2004,95(5):488-495.
[85] Kondrikov D,Han HR,Block ER,et al.Growth and density dependent regulation of NO synthase by the actin cytoskeleton in pulmonary artery endothelial cells.Am J Physiol Lung Cell Mol Physiol,2006,290(1):L41-50.
[86] Su Y,Kondrikov D,Block ER.Beta actin:a regulator of NOS 3.Sci STKE,2007,2007(404):pe52.
[87] Mi Q,Chen N,Shaifta Y,et al.Activation of endothelial nitric oxide synthase is dependent on its interaction with globular actin in human umbilical vein endothelial cells.J Mol Cell Cardiol,2011,51(3):419-427.
[88] Kanzaki M,Pessin JE.Caveolin associated filamentous actin (Cav actin) defines a novel F actin structure in adipocytes.J Biol Chem,2002,277(29):25867-25869.
[89] Nishida E,Koyasu S,Sakai H,et al.Calmodulin regulated binding of the 90 kDa heat shock protein to actin filaments.J Biol Chem,1986,261(34):16033-16036.
[90] Koyasu S,Nishida E,Kadowaki T,et al.Two mammalian heat shock proteins,HSP90 and HSP100,are actin binding proteins.Proc Natl Acad Sci USA,1986,83(21):8054-8058.
[91] Czar MJ,Welsh MJ,Pratt WB.Immunofluorescence localization of the 90 kDa heat shock protein to cytoskeleton.Eur J Cell Biol,1996,70(4):322-330.
[92] Orth JD,McNiven MA.Dynamin at the actin membrane interface.Curr Opin Cell Biol,2003,15(1):31-39.
[93] Zharikov SI,Block ER.Association of L arginine transporters with fodrin:implications for hypoxic inhibition of arginine uptake.Am J Physiol Lung Cell Mol Physiol,2000,278(1):L111-117.
[94] Zimmermann K,Opitz N,Dedio J,et al.NOSTRIN:a protein modulating nitric oxide release and subcellular distribution of endothelial nitric oxide synthase.Proc Natl Acad Sci USA,2002,99(26):17167-17172.
[95] Ji Y,Ferracci G,Warley A,et al.beta Actin regulates platelet nitric oxide synthase 3 activity through interaction with heat shock protein 90.Proc Natl Acad Sci USA,2007,104(21):8839-8844.
[96] Hoang HH,Padgham SV,Meininger CJ.L arginine,tetrahydrobiopterin,nitric oxide and diabetes.Curr Opin Clin Nutr Metab Care,2013,16(1):76-82.
[97] Roe ND,Ren J.Nitric oxide synthase uncoupling:a therapeutic target in cardiovascular diseases.Vascul Pharmacol,2012,57(5-6):168-172.
[98] Gielis JF,Lin JY,Wingler K,et al.Pathogenetic role of eNOS uncoupling in cardiopulmonary disorders.Free Radic Biol Med,2011,50(7):765-776.
[99] Kuzkaya N,Weissmann N,Harrison DG,et al.Interactions of peroxynitrite,tetrahydrobiopterin,ascorbic acid,and thiols:implications for uncoupling endothelial nitric oxide synthase.J Biol Chem,2003,278(25):22546-22554.
[100] Ji Y,Diao J,Han Y,et al.Pyridoxine prevents dysfunction of endothelial cell nitric oxide production in response to low density lipoprotein.Atherosclerosis,2006,188(1):84-94.
[101] Wu Y,Liu Y,Han Y,et al.Pyridoxine increases nitric oxide biosynthesis in human platelets.Int J Vitam Nutr Res,2009,79(2):95-103.
[102] Xie L,Liu Z,Lu H,et al.Pyridoxine inhibits endothelial NOS uncoupling induced by oxidized low density lipoprotein via the PKCα signalling pathway in human umbilical vein endothelial cells.Br J Pharmacol,2012,165(3):754-64.
[103] Shin S,Mohan S,Fung HL.Intracellular L arginine concentration does not determine NO production in endothelial cells:implications on the “L arginine paradox”.Biochem Biophys Res Commun,2011,414(4):660-663.
[104] Queen LR,Ji Y,Xu B,et al.Mechanisms underlying beta2 adrenoceptor mediated nitric oxide generation by human umbilical vein endothelial cells.J Physiol,2006,576(Pt 2):585-594.
[105] Zimmermann K,Opitz N,Dedio J,et al.NOSTRIN:a protein modulating nitric oxide release and subcellular distribution of endothelial nitric oxide synthase.Proc Natl Acad Sci USA,2002,99(26):17167-17172.
[106] Schilling K,Opitz N,Wiesenthal A,et al.Translocation of endothelial nitric oxide synthase involves a ternary complex with caveolin 1 and NOSTRIN.Mol Biol Cell,2006,17(9):3870-3880.
[107] Dedio J,Knig P,Wohlfart P,et al.NOSIP,a novel modulator of endothelial nitric oxide synthase activity.FASEB J,2001,15(1):79-89.
[108] Wang Z,Humphrey C,Frilot N,et al.Dynamin2 and endothelial nitric oxide synthase regulated invasion of bladder epithelial cells by uropathogenic Escherichia coli.J Cell Biol,2011,192(1):101-110.
